# Revisions to the Requirements Applicable to Blood, Blood Components, and Source Plasma
> **Food and Drug Administration** · Final rule. · Published 2001-08-06 · Effective 2001-09-05 · 66 FR 40886
## Document
- **Document number:** 01-19461
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 66 FR 40886
- **CFR reference:** 21 CFR 606
- **Publication date:** 2001-08-06
- **Effective date:** 2001-09-05
- **HHS docket:** Docket No. 98N-0673
## Abstract

The Food and Drug Administration (FDA) is amending the biologics regulations by removing, revising, or updating specific regulations applicable to blood, blood components, and Source Plasma to be more consistent with current practices in the blood industry and to remove unnecessary or outdated requirements. FDA is issuing this final rule as part of the agency's "Blood Initiative" in which FDA is reviewing and revising, when appropriate, its regulations, policies, guidance, and procedures related to blood, blood components, and Source Plasma.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2001/08/06/01-19461/revisions-to-the-requirements-applicable-to-blood-blood-components-and-source-plasma)
---
*AI Analytics · CC0 1.0*